'Cats Crush Cancer
Team Captain: Ms. Devon K. Healy
Bike Count:
Four-Bike Team
Per Bike Average: $14,688
Location: New York, NY:
Date:
Time:
ABOUT 'CATS CRUSH CANCER
In our third year, our team has grown significantly and we are bringing it back to NYC this year after participating in San Fran last year.
The majority of our team is some combination of Villanova classmates, roommates, lacrosse teammates and sorority sisters (and some sibling honorary wildcats!) and we are riding in support of every person who is currently undergoing treatment, who has been impacted by a family member with cancer or who could be in the future but specifically riding to honor our dear Villanova friends who have been successfully treated for cancer at MSK, Elizabeth Firth (Nova '03) and future Wildcat Class of 2043, Will Bonichi, son of Anna Lisa (Giustini) Bonichi ('Nova '02).
In February 2021, Will was diagnosed with Stage IV High Risk Neuroblastoma at 14 months old. Neuroblastoma is a rare and aggressive cancer the forms from immature nerve cells and most often occurs in children under the age of 5. At the time of diagnosis, the cancer had metastasized to 12 areas of Will's body including his bone marrow. Over the course of more than a year, he underwent an aggressive treatment plan that included high dose chemo, proton radiation, major surgeries and immunotherapy. Through treatment, Will earned his nickname "Will the Warrior" showing us how to battle the disease with strength, courage and perseverance. Today, Will is 5 years old, cancer free and thriving. He is currently enrolled in a neuroblastoma vaccine clinical trial at MSK until 2026.
Will's family formed the Will the Warrior Foundation (a registered 501c) in 2022 to raise awareness and funds for neuroblastoma research as well as support other families impacted by the disease. Currently high risk neuroblastoma has a 65% relapse rate and 50% survival rate. Our hope is that with increased funding for research for more targeted and less toxic treatment options, the survival rates will continue to improve and one day a cure will be found.
Every dollar makes a difference because 100% of all funds raised through Cycle for Survival go directly to rare cancer research at MSK. Our team has elected to direct our funds to Neuroblastoma research.
Thank you for your generosity!
| The Cycle for Survival Web page and e-mail are provided as a courtesy to participants to help them manage fundraising efforts for this event. Memorial Sloan Kettering Cancer Center or any of its affiliated organizations, or their officers, directors, agents, or employees do not control, nor are they responsible for, the contents of this Web page. Any views or information provided on this Web page are the sole responsibility of the participant. The participant's Web page may provide links to other Web sites and does not imply an endorsement by MSKCC, its affiliated organizations, their officers, directors, agents, and employees of the materials contained at those Web sites. |